Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | IDH2 | P48735 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22607499 | 0.94 | — | — | |
| SCHEMBL7510367 | 0.63 | GPR3 (0.36) | MEN1KMT2AATM | |
| SCHEMBL6273804 | 0.62 | ESR1 (0.37) | MEN1KMT2AATM | |
| SCHEMBL7632190 | 0.62 | HRH1 (0.40) | MAPTATM | |
| Hydrochloric Acid SCHEMBL6862745 | 0.61 | GPR3 (0.34) | MEN1KMT2AATM | |
| Hydrochloric Acid SCHEMBL7645556 | 0.59 | SLC6A3 (0.38) | MEN1KMT2AMAPTATM | |
| SCHEMBL11540362 | 0.59 | ATM (0.38) | IDH2ATM | |
| SCHEMBL6902982 | 0.59 | ESR1 (0.39) | MAPTATM | |
| SCHEMBL686819 | 0.58 | ATM (0.36) | IDH2ATM | |
| Biphenyl SCHEMBL27745920 | 0.58 | ALDH1A1 (0.69) | MAPTATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6946531-B2 | Low molecular weight ethylene interpolymers and polymerization process | DOW GLOBAL TECHNOLOGIES INC. (US) | 2005-09-20 | — | — | US | disclosed |
| EP-1389215-B1 | 3-ARYL-SUBSTITUTED CYCLOPENTADIENYL METAL COMPLEXES AND POLYMERIZATION PROCESS | DOW GLOBAL TECHNOLOGIES INC (US) | 2005-06-15 | — | — | EP | disclosed |
| US-6825147-B2 | (3,4-DIPHENYLCYCLOPENTADIEN-1-YL)DIMETHYL(T-BUTYLAMIDO) -SILANETITANIUM DICHLORIDE, FOR EXAMPLE; FOR COPOLYMERIZATION OF ETHYLENE AND STYRENE | DOW GLOBAL TECHNOLOGIES INC. | 2004-11-30 | — | — | US | disclosed |
| US-20040092680-A1 | Addition copolymerization using titanium complexes comprising a 3-aryl-substituted cyclopentadienyl ring as polymerization catalyst | DOW GLOBAL TECHNOLOGIES LLC | 2004-05-13 | — | — | US | disclosed |
| EP-1389215-A1 | 3-ARYL-SUBSTITUTED CYCLOPENTADIENYL METAL COMPLEXES AND POLYMERIZATION PROCESS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2004-02-18 | — | — | EP | disclosed |
| US-20020183464-A1 | 3-aryl-substituted cyclopentadienyl metal complexes and polymerization process | DOW GLOBAL TECHNOLOGIES LLC | 2002-12-05 | — | — | US | disclosed |
| WO-2002092610-A1 | 3-ARYL-SUBSTITUTED CYCLOPENTADIENYL METAL COMPLEXES AND POLYMERIZATION PROCESS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2002-11-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020183464-A1 | 3-aryl-substituted cyclopentadienyl metal complexes and polymerization process | SOD1, AOC3, PPOX | MEN1 4838/4885KMT2A 2742/4885IDH2 2359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.